
Prostatic cancers include a diverse microenvironment of tumor cells, cancer‐associated fibroblasts, and immune components. The paper presents methods for clinical case identification, tissue processing, and analytical workflow that are compatible with standard histopathology while enabling molecular and functional interrogation of prostate TME components. The use of these techniques enables translational research and the development of molecular and functional assays to facilitate prostate TME study without compromising standard‐of‐care histopathological diagnosis. This allows bridging clinical histopathology and further interrogation of the prostate TME and promises to advance our understanding of tumor biology and unveil new predictive and prognostic markers of prostate cancer progression.
Like
Save
Share